PhD Position - Development of a novel regulatory T cell therapy for type 1 diabetes - European project ARTiDe
ABG-124976 | Thesis topic | |
2024-07-08 | Public/private mixed funding |
![Logo de](/images/cache/200_fec4575932021cdc219c4adbe8b6b04786d3975d.jpg)
- Health, human and veterinary medicine
- Biology
Topic description
Type 1 diabetes (T1D) is an incurable disease, often starting in childhood, caused by the autoimmune destruction of insulin-producing beta cells, yet the standard of care is insulin replacement, acting only at the symptom level. Thus, T1D is a disease with a high unmet need for innovative therapy.
Our goal is to develop a cell-based therapy using TCR-engineered Tregs for cell therapy in T1D.
This project is funded via the European consortium ARTiDe coordinated by S. Fillatreau. ARTiDe involves 8 partners providing novel technologies for the systematic identification of autoantigen-specific Tregs and Teffs in humans, the selection of optimal TCR to produce protective Tregs, innovative humanized T1D pre-clinical models to test their efficacy and safety, the development of industrial process for TCR-engineered Treg production, and new Treg supporting strategies in vivo.
Funding category
Funding further details
Presentation of host institution and host laboratory
Institut Necker Enfants Malades (INEM) is a biomedical research center located on the Necker campus. It benefits from numerous state-of-the-art core facilities. The Campus has a long-standing reputation for scientific excellence and key pioneering medical contributions (transplantation, biotherapy, gene therapy). It provides a vibrant environment for basic research and translational innovation.
The Immunity in Heath and Disease team, led by Simon Fillatreau, investigates the roles of B and T cells in autoimmune and infectious diseases, with a particular emphasis on identifying and characterizing novel pro-inflammatory and anti-inflammatory T cell, B cell and plasma cell subsets.
Candidate's profile
For PhD position:
Candidates must have a Master degree in Science, strong knowledge in Immunology is highly prefered. Candidates who are motivated, self-driven, independent, and creative with strong organizational, writing, and communication skills are encouraged to apply. Fluency in English and the ability to work in a multicultural environment are essential. Working with murine model is expected.
The PhD student will learn to work on 1) the molecular characterization of autoreactive Teffs and Tregs at single cell level in patients with T1D and control in order to decipher the basis for the loss of immunological tolerance in this human disease, as well on 2) the evaluation of the selected autoreactive TCR obtained through the single cell studies above for their capacity to produce protective Tregs using a novel humanized model for T1D.
Vous avez déjà un compte ?
Nouvel utilisateur ?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Discover our members
MabDesign
CASDEN
Laboratoire National de Métrologie et d'Essais - LNE
ADEME
Nokia Bell Labs France
ONERA - The French Aerospace Lab
Aérocentre, Pôle d'excellence régional
CESI
Tecknowmetrix
SUEZ
Institut de Radioprotection et de Sureté Nucléaire - IRSN - Siège
Généthon
Groupe AFNOR - Association française de normalisation
Ifremer
ANRT
PhDOOC
Institut Sup'biotech de Paris
MabDesign
TotalEnergies
-
JobFixed-termRef. ABG125071KTH- Sweden
ERC-funded postdoc position on the detection of gas-phase organic radicals, KTH, Stockholm, Sweden
Chemistry - Physics - Engineering sciencesAny -
JobPermanentRef. ABG123642Laboratoire des Courses Hippiques (GIE LCH)- Ile-de-France - France
Chargé(e) de Recherche et Innovation (H/F) / Senior Scientist Research & Innovation (M/F)
Chemistry - BiochemistryConfirmed -
JobPermanentRef. ABG124941Corteria Pharmaceuticals- Ile-de-France - France
Jeune Docteur, Chercheur en Biologie Cellulaire & Moléculaire (H/F)
BiologyAny